Psoriasis: clinical and epidemiological features and therapy issues

Aim. This study sets out to establish the demographic and clinical features of psoriasis and its co-morbidities; to describe approaches to treating patients in Russia, to whom the systemic therapy of drugs has been recommended; to assess the effects of this dermatosis on the patients' quality o...

Full description

Bibliographic Details
Main Authors: A. L. Bakulev, T. V. Fitileva, E. А. Novodezerkina, I. Gilloteau, Н. Tian, T. Howe, G. Pietri
Format: Article
Language:English
Published: State Scientific Center of Dermatovenereology and Cosmetology 2018-08-01
Series:Vestnik Dermatologii i Venerologii
Subjects:
Online Access:https://www.vestnikdv.ru/jour/article/view/407
_version_ 1797709011929268224
author A. L. Bakulev
T. V. Fitileva
E. А. Novodezerkina
I. Gilloteau
Н. Tian
T. Howe
G. Pietri
author_facet A. L. Bakulev
T. V. Fitileva
E. А. Novodezerkina
I. Gilloteau
Н. Tian
T. Howe
G. Pietri
author_sort A. L. Bakulev
collection DOAJ
description Aim. This study sets out to establish the demographic and clinical features of psoriasis and its co-morbidities; to describe approaches to treating patients in Russia, to whom the systemic therapy of drugs has been recommended; to assess the effects of this dermatosis on the patients' quality of life and work productivity; to assess the degree of consistency between dermatologists' and patients' estimates concerning the severity of the disease, complaints/objective manifestations and treatment satisfaction.Methods. Data from the GfK Disease Atlas was used. This ATLAS was filed within a global programme Growth from Knowledge that collected reliable data in the context of everyday clinical practice in 9 countries. The paper presents the results solely for the Russian sample. The study involved patients with moderate or severe psoriasis who were receiving systemic therapy for this disease. Using specially developed forms, ATLAS specialists registered data about patients, their disease and received treatment. The patients affected by psoriasis, who participated in the study, were questioned about their disease. Dermatologists assessed the severity of psoriasis, the patients' complaints, co-morbidities and received treatment. The patients completed questionnaires aimed at assessing the quality of their life [Dermatology Life Quality Index, DLQI] and their work productivity [Work Productivity and Activity Impairment, WPAI]. The concordance between the patients' and the dermatologists' estimates was assessed using Cohen's kappa coefficient.Results. Overall, 3,821 patients participated in the ATLAS programme, out of whom 300 patients were Russians. The average time since psoriasis diagnosis amounted to 9.9 years. 51 % of the patients complained about itching in the lesion areas. Psoriatic arthritis was registered in 19 % of the cases. Among co-morbidities, anxiety or depression was most often recorded (11 %, respectively). The proportion of patients with pruritus and related comorbid conditions increased with psoriasis severity. The disease negatively affected the quality of patients’ life (the average value of DLQI was 7.1) and their work productivity (a decrease in the work productivity reached 33.2 %), with these indicators deteriorating with psoriasis severity. Despite the dominance of moderate and severe psoriasis forms among the participants, 60 % of the patients received therapy only with topical medications. The concordance rate between the patients and the dermatologists concerning the estimation of psoriasis severity and treatment satisfaction was low.Conclusion. Despite the therapy with systemic drugs, the patients' quality of life affected by severe or moderate psoriasis forms remained low. The consistency between the views on the treatment success between the patients and the dermatologists was low.
first_indexed 2024-03-12T06:31:07Z
format Article
id doaj.art-7dd51781f401462fa4c01aa410474604
institution Directory Open Access Journal
issn 0042-4609
2313-6294
language English
last_indexed 2024-03-12T06:31:07Z
publishDate 2018-08-01
publisher State Scientific Center of Dermatovenereology and Cosmetology
record_format Article
series Vestnik Dermatologii i Venerologii
spelling doaj.art-7dd51781f401462fa4c01aa4104746042023-09-03T01:39:01ZengState Scientific Center of Dermatovenereology and CosmetologyVestnik Dermatologii i Venerologii0042-46092313-62942018-08-01943677610.25208/0042-4609-2018-94-3-67-76381Psoriasis: clinical and epidemiological features and therapy issuesA. L. Bakulev0T. V. Fitileva1E. А. Novodezerkina2I. Gilloteau3Н. Tian4T. Howe5G. Pietri6Saratov State Medical Universit y of the Ministr y of Healthcare of the Russian FederationProvyantskaya str., 22, Saratov, 410028Provyantskaya str., 22, Saratov, 410028Novartis Pharma AGNovartis Pharmaceuticals CoGfK CompanyData Pyxis LtdAim. This study sets out to establish the demographic and clinical features of psoriasis and its co-morbidities; to describe approaches to treating patients in Russia, to whom the systemic therapy of drugs has been recommended; to assess the effects of this dermatosis on the patients' quality of life and work productivity; to assess the degree of consistency between dermatologists' and patients' estimates concerning the severity of the disease, complaints/objective manifestations and treatment satisfaction.Methods. Data from the GfK Disease Atlas was used. This ATLAS was filed within a global programme Growth from Knowledge that collected reliable data in the context of everyday clinical practice in 9 countries. The paper presents the results solely for the Russian sample. The study involved patients with moderate or severe psoriasis who were receiving systemic therapy for this disease. Using specially developed forms, ATLAS specialists registered data about patients, their disease and received treatment. The patients affected by psoriasis, who participated in the study, were questioned about their disease. Dermatologists assessed the severity of psoriasis, the patients' complaints, co-morbidities and received treatment. The patients completed questionnaires aimed at assessing the quality of their life [Dermatology Life Quality Index, DLQI] and their work productivity [Work Productivity and Activity Impairment, WPAI]. The concordance between the patients' and the dermatologists' estimates was assessed using Cohen's kappa coefficient.Results. Overall, 3,821 patients participated in the ATLAS programme, out of whom 300 patients were Russians. The average time since psoriasis diagnosis amounted to 9.9 years. 51 % of the patients complained about itching in the lesion areas. Psoriatic arthritis was registered in 19 % of the cases. Among co-morbidities, anxiety or depression was most often recorded (11 %, respectively). The proportion of patients with pruritus and related comorbid conditions increased with psoriasis severity. The disease negatively affected the quality of patients’ life (the average value of DLQI was 7.1) and their work productivity (a decrease in the work productivity reached 33.2 %), with these indicators deteriorating with psoriasis severity. Despite the dominance of moderate and severe psoriasis forms among the participants, 60 % of the patients received therapy only with topical medications. The concordance rate between the patients and the dermatologists concerning the estimation of psoriasis severity and treatment satisfaction was low.Conclusion. Despite the therapy with systemic drugs, the patients' quality of life affected by severe or moderate psoriasis forms remained low. The consistency between the views on the treatment success between the patients and the dermatologists was low.https://www.vestnikdv.ru/jour/article/view/407psoriasisquality of lifereal clinical practice studytherapeutic approaches
spellingShingle A. L. Bakulev
T. V. Fitileva
E. А. Novodezerkina
I. Gilloteau
Н. Tian
T. Howe
G. Pietri
Psoriasis: clinical and epidemiological features and therapy issues
Vestnik Dermatologii i Venerologii
psoriasis
quality of life
real clinical practice study
therapeutic approaches
title Psoriasis: clinical and epidemiological features and therapy issues
title_full Psoriasis: clinical and epidemiological features and therapy issues
title_fullStr Psoriasis: clinical and epidemiological features and therapy issues
title_full_unstemmed Psoriasis: clinical and epidemiological features and therapy issues
title_short Psoriasis: clinical and epidemiological features and therapy issues
title_sort psoriasis clinical and epidemiological features and therapy issues
topic psoriasis
quality of life
real clinical practice study
therapeutic approaches
url https://www.vestnikdv.ru/jour/article/view/407
work_keys_str_mv AT albakulev psoriasisclinicalandepidemiologicalfeaturesandtherapyissues
AT tvfitileva psoriasisclinicalandepidemiologicalfeaturesandtherapyissues
AT eanovodezerkina psoriasisclinicalandepidemiologicalfeaturesandtherapyissues
AT igilloteau psoriasisclinicalandepidemiologicalfeaturesandtherapyissues
AT ntian psoriasisclinicalandepidemiologicalfeaturesandtherapyissues
AT thowe psoriasisclinicalandepidemiologicalfeaturesandtherapyissues
AT gpietri psoriasisclinicalandepidemiologicalfeaturesandtherapyissues